{'Year': '2012', 'Month': 'Oct'}
Ready when you are: easing into preemptive pharmacogenetics.
The promise of pharmacogenetics has included reduction of adverse drug events and enrichment for clinical efficacy. However, there has been very little assessment of the context in which this promise could be delivered. There are issues of return on effort and end points of meaningful impact that are crucial to moving this area of clinical pharmacology into practical benefit for our health system.